Literature DB >> 6235911

Activation of lymphocyte anti-tumor responses in man. Towards an understanding of effector cell heterogeneity?

B M Vose.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6235911     DOI: 10.1007/bf00200039

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


× No keyword cloud information.
  28 in total

1.  Generation of a cloned NK cell line derived from the "null cell" fraction of human peripheral blood.

Authors:  T Hercend; S Meuer; E L Reinherz; S F Schlossman; J Ritz
Journal:  J Immunol       Date:  1982-09       Impact factor: 5.422

2.  Cultured human T-cell lines kill autologous solid tumours.

Authors:  B M Vose; M Moore
Journal:  Immunol Lett       Date:  1981-10       Impact factor: 3.685

3.  Lysis of autologous human melanoma cells by in vitro allosensitized peripheral blood lymphocytes.

Authors:  G Fossati; A Balsari; D Taramelli; M L Sensi; G Pellegris; M Nava; G Parmiani
Journal:  Cancer Immunol Immunother       Date:  1982       Impact factor: 6.968

4.  Lysis of fresh human solid tumors by autologous lymphocytes activated in vitro with lectins.

Authors:  A Mazumder; E A Grimm; H Z Zhang; S A Rosenberg
Journal:  Cancer Res       Date:  1982-03       Impact factor: 12.701

5.  Quantitation of proliferative and cytotoxic precursor cells directed against human tumours: limiting dilution analysis in peripheral blood and at the tumour site.

Authors:  B M Vose
Journal:  Int J Cancer       Date:  1982-08-15       Impact factor: 7.396

6.  Human normal CTL clones: generation and properties.

Authors:  D Zagury; D Morgan; G Lenoir; M Fouchard; M Feldman
Journal:  Int J Cancer       Date:  1983-04-15       Impact factor: 7.396

7.  Cloned cell lines with natural killer activity. Specificity, function, and cell surface markers.

Authors:  G Dennert; G Yogeeswaran; S Yamagata
Journal:  J Exp Med       Date:  1981-03-01       Impact factor: 14.307

8.  Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus-derived lymphocytes, and natural killer cells.

Authors:  E A Grimm; K M Ramsey; A Mazumder; D J Wilson; J Y Djeu; S A Rosenberg
Journal:  J Exp Med       Date:  1983-03-01       Impact factor: 14.307

9.  Role of alloantigens in natural killing. Allogeneic but not autologous tumor biopsy cells are sensitive for interferon-induced cytotoxicity of human blood lymphcoytes.

Authors:  F T Vánky; S A Argov; S A Einhorn; E Klein
Journal:  J Exp Med       Date:  1980-05-01       Impact factor: 14.307

10.  Lysis of tumor biopsy cells by autologous T lymphocytes activated in mixed cultures and propagated with T cell growth factor.

Authors:  F Vánky; T Gorsky; Y Gorsky; M G Masucci; E Klein
Journal:  J Exp Med       Date:  1982-01-01       Impact factor: 14.307

View more
  3 in total

1.  Stimulation of peripheral blood lymphocytes with autologous tumor and serum-derived fractions from patients with laryngeal carcinomas.

Authors:  P Koldovsky; U Koldovsky; J Ebbers; K H Vosteen
Journal:  Arch Otorhinolaryngol       Date:  1986

2.  Influence in vitro on NK and K cell activities by cimetidine and indomethacin with and without simultaneous exposure to interferon.

Authors:  P Flodgren; H O Sjögren
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

Review 3.  Autologous cellular immune response to primary and metastatic human melanomas and its regulation by DR antigens expressed on tumor cells.

Authors:  G Parmiani; G Fossati; D Taramelli; A Anichini; A Balsari; C Gambacorti-Passerini; G Sciorelli; N Cascinelli
Journal:  Cancer Metastasis Rev       Date:  1985       Impact factor: 9.264

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.